Pacific Edge shares fall 63% after Novitas decision

Pacific Edge shares fall 63% after Novitas decision
(Image: Pacific Edge)
Rebecca Howard
Cancer diagnostics company Pacific Edge has come out swinging against a decision by Novitas, the Medicare administrative contractor with jurisdiction for its US laboratory, that would end reimbursement for Cxbladder Triage, Detect and Monitor. The shares fell 63% to $0.050 in early trading Monday after a trading halt was lifted.According to Pacific Edge, Novitas continues to misunderstand the current standard of care in evaluating hematuria patients, fails to consider new peer-reviewed evidence and repeats its flawed analysis of the existi...

More Markets

NZ sharemarket ends lower, spike in oil prices
Markets Market Close

NZ sharemarket ends lower, spike in oil prices

Australian, Hong Kong and Japanese share markets were all down after the attack.

Jamie Gray 13 Jun 2025
Bremworth wins $2m Kāinga Ora wool carpet contract
Primary Sector

Bremworth wins $2m Kāinga Ora wool carpet contract

The NZX-listed carpet market says the contract is of huge strategic value.

Staff reporters 13 Jun 2025
New Meridian boss warns market intervention comes with high risk
Markets

New Meridian boss warns market intervention comes with high risk

Mike Roan says electricity prices will come down in his term as CEO.

Ian Llewellyn 13 Jun 2025
NZ sharemarket flat amid global fears of Iran strike
Markets Market Close

NZ sharemarket flat amid global fears of Iran strike

NZ investors are looking with concern at rumblings in the Middle East.

Tom Raynel 12 Jun 2025